Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

42.75p
   
  • Change Today:
      0.75p
  • 52 Week High: 48.40
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 2,754,763
  • Market Cap: £231.09m
  • RiskGrade: 119

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
11.28% above the market average11.28% above the market average11.28% above the market average11.28% above the market average11.28% above the market average
Sector averageSector averageSector averageSector averageSector average
1yr Revenue Growth
7.92% above the market average7.92% above the market average7.92% above the market average7.92% above the market average7.92% above the market average
9.68% above the sector average9.68% above the sector average9.68% above the sector average9.68% above the sector average9.68% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
29.23% below the market average29.23% below the market average29.23% below the market average29.23% below the market average29.23% below the market average
78.57% below the sector average78.57% below the sector average78.57% below the sector average78.57% below the sector average78.57% below the sector average
Price Book Ratio
0.37% above the market average0.37% above the market average0.37% above the market average0.37% above the market average0.37% above the market average
51.22% above the sector average51.22% above the sector average51.22% above the sector average51.22% above the sector average51.22% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
89.52% above the market average89.52% above the market average89.52% above the market average89.52% above the market average89.52% above the market average
83.67% above the sector average83.67% above the sector average83.67% above the sector average83.67% above the sector average83.67% above the sector average
Price Chg 3m
87.30% above the market average87.30% above the market average87.30% above the market average87.30% above the market average87.30% above the market average
75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
82.90% above the market average82.90% above the market average82.90% above the market average82.90% above the market average82.90% above the market average
86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average
Momentum 20
71.55% above the market average71.55% above the market average71.55% above the market average71.55% above the market average71.55% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
55.49% below the market average55.49% below the market average55.49% below the market average55.49% below the market average55.49% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
12.34% above the market average12.34% above the market average12.34% above the market average12.34% above the market average12.34% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Forecast EPS
61.36% below the market average61.36% below the market average61.36% below the market average61.36% below the market average61.36% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
39.43% above the market average39.43% above the market average39.43% above the market average39.43% above the market average39.43% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Operating Profit Loss
94.43% below the market average94.43% below the market average94.43% below the market average94.43% below the market average94.43% below the market average
87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
41.89% above the market average41.89% above the market average41.89% above the market average41.89% above the market average41.89% above the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average
Cash
35.14% above the market average35.14% above the market average35.14% above the market average35.14% above the market average35.14% above the market average
58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
61.12% below the market average61.12% below the market average61.12% below the market average61.12% below the market average61.12% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average
Buys 1y
94.09% below the market average94.09% below the market average94.09% below the market average94.09% below the market average94.09% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
49.21% below the market average49.21% below the market average49.21% below the market average49.21% below the market average49.21% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Brokers Percent Neutral
38.46% above the market average38.46% above the market average38.46% above the market average38.46% above the market average38.46% above the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 42.75p
Change Today 0.75p
% Change 1.79 %
52 Week High 48.40
52 Week Low 29.35
Volume 2,754,763
Shares Issued 540.57m
Market Cap £231.09m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.58% above the market average12.58% above the market average12.58% above the market average12.58% above the market average12.58% above the market average
91.84% above the sector average91.84% above the sector average91.84% above the sector average91.84% above the sector average91.84% above the sector average
Price Trend
22.33% below the market average22.33% below the market average22.33% below the market average22.33% below the market average22.33% below the market average
22.45% above the sector average22.45% above the sector average22.45% above the sector average22.45% above the sector average22.45% above the sector average
Income Not Available
Growth
41.79% below the market average41.79% below the market average41.79% below the market average41.79% below the market average41.79% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 11-Sep-2024

Time Volume / Share Price
17:06 599,486 @ 42.75p
16:35 5,829 @ 42.75p
16:35 16,799 @ 42.75p
16:35 109,149 @ 42.75p
16:35 1 @ 42.75p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page